Buy Aurobindo Pharma, target price Rs 742: ICICI Direct

economictimes.indiatimes.com:

Aurobindo Pharma with a target price of Rs 742. The current market price of Aurobindo Pharma is Rs 746.Time period given by analyst is Intra Day when Aurobindo Pharma price can reach defined target.

ICICI Direct recommended to keep stoploss at Rs 726.3. Aurobindo Pharma, incorporated in the year 1986, is a Large Cap company (having a market cap of Rs 43801.84 Crore) operating in Pharmaceuticals sector.

Aurobindo Pharma key Products/Revenue Segments include Pharmaceuticals, Sale of services, Export Incentives and Scrap for the year ending 31-Mar-2022.Financials For the quarter ended 31-03-2023, the company has reported a Consolidated Total Income of Rs 6607.87 Crore, up 1.66 % from last quarter Total Income of Rs 6499.78 Crore and up 12.80 % from last year same quarter Total Income of Rs 5858.25 Crore. Company has reported net profit after tax of Rs 511.77 Crore in latest quarter.Investment Rationale Price rebounding after taking support at 13 day EMA further upsides in coming sessionsPromoter/FII HoldingsPromoters held 51.83 per cent stake in the company as of 31-Mar-2023, while FIIs owned 23.03 per cent, DIIs 15.09 per cent.